PCSK9 and cardiovascular disorder: In addition, circulating PCSK9 levels were significantly associated with cardiovascular diseases (CVD) among systemic lupus erythematosus (SLE) patients10, wherein Ox-LDL-induced dendritic cell maturation was inhibited by PCSK9 inhibition10.